Monoclonal T-cell dyscrasia of undetermined significance associated with recalcitrant erythroderma

Archives of Dermatology

Volumn 141, Issue 3, 2005, Pages 361-367

  Gniadecki, Robert ^a,c   Lukowsky, Ansgar ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD134 ANTIGEN; CD27 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CUTANEOUS LYMPHOCYTE ANTIGEN; DIPEPTIDYL PEPTIDASE IV; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE SURFACE MARKER; T CELL RECEPTOR ALPHA BETA; T CELL RECEPTOR GAMMA DELTA; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR GAMMA; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTOMATION; BLOOD DYSCRASIA; CELL POPULATION; CHRONIC DISEASE; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROPHORESIS; ERYTHRODERMA; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; IDIOPATHIC DISEASE; LIFESPAN; LYMPHOCYTE CLONE; LYMPHOCYTE SUBPOPULATION; MALE; MONOCLONAL T CELL DYSCRASIA; PATIENT; PERIPHERAL LYMPHOCYTE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECALCITRANT ERYTHRODERMA; SCREENING; SEZARY SYNDROME; SKIN; SKIN LYMPHOMA; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GAMMA GENE; T LYMPHOCYTE RECEPTOR GENE;

EID: 14944379155     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.3.361     Document Type: Article

References (49)

1. Sigurdsson V, Steegmans PH, van Vloten WA. The incidence of erythroderma: a survey among all dermatologists in the Netherlands. J Am Acad Dermatol. 2001;45:675-678.
2. Botella-Estrada R, Sanmartin O, Oliver V, Febrer I, Aliaga A. Erythroderma: a clinicopathological study of 56 cases. Arch Dermatol. 1994;130:1503-1507.
3. Sigurdsson V, Toonstra J, van Vloten WA. Idiopathic erythroderma: a follow-up study of 28 patients. Dermatology. 1997;194:98-101.
4. Thestrup-Pedersen K, Halkier-Sorensen L, Sogaard H, Zachariae H. The red man syndrome: exfoliative dermatitis of unknown etiology: a description and follow-up of 38 patients. J Am Acad Dermatol. 1988;18:1307-1312.
5. Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol. 2002;46:95-106.
6. Buechner SA, Winkelmann RK. Pre-Sézary erythroderma evolving to Sézary syndrome: a report of seven cases. Arch Dermatol. 1983;119:285-291.
7. Lange-Vejlsgaard G, Ralfkiaer E, Larsen JK, O'Connor N, Thomsen K. Fatal cutaneous T cell lymphoma in a child with atopic dermatitis. J Am Acad Dermatol. 1989;20:954-958.
8. Rajka G, Winkelmann RK. Atopic dermatitis and Sézary syndrome. Arch Dermatol. 1984;120:83-84.
9. Van Haselen CW, Toonstra J, Preesman AH, Van Der Putte SC, Bruijnzeel-Koomen CA, van Vloten WA. Sézary syndrome in a young man with severe atopic dermatitis. Br J Dermatol. 1999;140:704-707.
10. Winkelmann RK, Perry HO, Muller SA, Schroeter AL, Jordon RE, Rogers RS III. The pre-Sézary erythroderma syndrome. Mayo Clin Proc. 1974;49:588-589.
11. Winkelmann RK, Rajka G. Atopic dermatitis and Hodgkin's disease. Acta Derm Venereol. 1983;63:176-177.
12. Russell-Jones R, Whittaker S. T-cell receptor gene analysis in the diagnosis of Sézary syndrome. J Am Acad Dermatol. 1999;41:254-259.
13. Dummer R, Nestle FO, Niederer E, et al. Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome. Arch Dermatol Res. 1999;291:307-311.
14. - subset in the identification of circulating Sézary cells. Br J Dermatol. 2001;144:125-135.
15. - T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome. J Am Acad Dermatol. 2001;44:456-461.
16. Vonderheid EC, Bigler RD, Kotecha A, et al. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). J Invest Dermatol. 2001;117:654-662.
17. - T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. J Invest Dermatol. 2000;114:107-111.
18. - lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis. Arch Dermatol. 2002;138:1347-1350.
19. Clatch RJ, Walloch JL, Zutter MM, Kamentsky LA. Immunophenotypic analysis of hematologic malignancy by laser scanning cytometry. Am J Clin Pathol. 1996;105:744-755.
20. Clatch RJ, Foreman JR, Walloch JL. Simplified immunophenotypic analysis by laser scanning cytometry. Cytometry. 1998;34:3-16.
21. Clatch RJ, Foreman JR. Five-color immunophenotyping plus DNA content analysis by laser scanning cytometry. Cytometry. 1998;34:36-38.
22. Clatch RJ. Immunophenotyping of hematological malignancies by laser scanning cytometry. Methods Cell Biol. 2001;64:313-342.
23. Gniadecki R, Lukowsky A, Rossen K, Madsen HO, Thomsen K, Wulf HC. Bone marrow precursor of extranodal T-cell lymphoma. Blood. 2003;102:3797-3799.
24. Lukowsky A. Clonality analysis by T-cell receptor gamma PCR and high-resolution electrophoresis in the diagnosis of cutaneous T-cell lymphoma (CTCL). Methods Mol Biol. 2003;218:303-320.
25. Lukowsky A, Richter S, Dijkstal K, Sterry W, Muche JM. A T-cell receptor gamma polymerase chain reaction assay using capillary electrophoresis for the diagnosis of cutaneous T-cell lymphomas. Diagn Mol Pathol. 2002;11:59-66.
26. Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564-569.
27. Han T, Ozer H, Gavigan M, et al. Benign monoclonal B cell lymphocytosis: a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients. Blood. 1984;64:244-252.
28. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". J Exp Med. 1994;179:609-618.
29. + cells with identical CDR3 sequences. Clin Immunol Immunopathol. 1998;89:61-70.
30. + T-cell clones in old mice. Immunol Rev. 1997;160:139-144.
31. Bigouret V, Hoffmann T, Arlettaz L, et al. Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood. 2003;101:3198-3204.
32. Pandolfi F, Loughran TP Jr, Starkebaum G, et al. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes: a multicenter study. Cancer. 1990;65:341-348.
33. + large granular lymphocyte (LGL)/NK-associated (NKa) expansions: primary malignancies or secondary reactive phenomena? Leuk Lymphoma. 1995;17:303-311.
34. De Rie MA, Cairo I, Van Lier RA, Bos JD. Expression of the T-cell activation antigens CD27 and CD28 in normal and psoriatic skin. Clin Exp Dermatol. 1996;21:104-111.
35. Jung T, Schulz S, Zachmann K, Neumann C. Expansion and proliferation of skin-homing T cells in atopic dermatitis as assessed at the single-cell level. Int Arch Allergy Immunol. 2003;130:143-149.
36. Moll M, Reinhold U, Kukel S, et al. CD7-negative helper T cells accumulate in inflammatory skin lesions. J Invest Dermatol. 1994;102:328-332.
37. - T lymphocytes during HIV-1 infection. J Acquir Immune Defic Syndr. 1994;7:245-253.
38. Liuzzo G, Kopecky SL, Frye RL, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135-2139.
39. - costimulation-independent T cells in multiple sclerosis. J Clin Invest. 2001;108:1185-1194.
40. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97:2027-2037.
41. Vallejo AN, Weyand CM, Goronzy JJ. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med. 2004;10:119-124.
42. - T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum. 2001;44:13-20.
43. + T cell clones in older mice is controlled by cytokines. J Immunol. 2001;166:2186-2193.
44. null T cells are associated with defects in apoptotic pathways. J Immunol. 2000;165:6301-6307.
45. Vallejo AN, Brandes JC, Weyand CM, Goronzy JJ. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol. 1999;162:6572-6579.
46. Vallejo AN, Weyand CM, Goronzy JJ. Functional disruption of the CD28 gene transcriptional initiator in senescent T cells. J Biol Chem. 2001;276:2565-2570.
47. Vallejo AN, Bryl E, Klarskov K, Naylor S, Weyand CM, Goronzy JJ. Molecular basis for the loss of CD28 expression in senescent T cells. J Biol Chem. 2002;277:46940-46949.
48. Warrington KJ, Vallejo AN, Weyand CM, Goronzy JJ. CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation. Blood. 2003;101:3543-3549.
49. null T cells. J Immunol. 2002;168:3839-3846.